The impact of hospitalised patients with COPD: from admission to outcome

Patients admitted with a COPD related event. Granular care pathways. Multi-morbidity, investigations, interventions and treatments. Serial physiology, blood biomarkers, physiotherapy, outcome. Deeply phenotyped. The impact of hospitalised patients with COPD: from admission to outcome Dataset 13.0 Background. Chronic obstructive pulmonary disease (COPD) is a debilitating lung condition characterised by progressive lung function limitation. COPD is an umbrella term and encompasses a spectrum of pathophysiologies including chronic bronchitis, small airways disease and emphysema. COPD caused an estimated 3 million deaths worldwide in 2016, and is estimated to be the third leading cause of death worldwide. People with COPD experience flares in their symptoms, termed exacerbations. Exacerbations are associated with increased mortality, morbidity, a faster decline in lung function and other systemic illness such as heart attacks and strokes. Despite this impact, COPD exacerbations are poorly characterised and have been without novel treatments for >30 years. PIONEER geography The West Midlands (WM) has a population of 5.9 million & includes a diverse ethnic & socio-economic mix. There is a higher than average percentage of minority ethnic groups. The West Midlands has a high prevalence of COPD, reflecting the high rates of smoking and industrial exposure. Each day >100,000 people are treated in hospital, see their GP or are cared for by the NHS. EHR. University Hospitals Birmingham NHS Foundation Trust (UHB) is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds & 100 ITU beds. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health”. Scope: All hospitalised patients admitted to UHB with an exacerbation of COPD from Jan 2000 - 2021. Longitudinal & individually linked, so that the preceding & subsequent health journey can be mapped & healthcare utilisation prior to & after admission understood. The dataset includes ICD-10 & SNOMED-CT codes pertaining to COPD and COPD exacerbations, as well as all co-morbid conditions. Serial, structured data pertaining to process of care (timings, staff grades, specialty review, wards), presenting complaint, all physiology readings (pulse, blood pressure, respiratory rate, oxygen saturations), all blood results, microbiology, all prescribed & administered treatments (NIV, nebulisers, antibiotics), all outcomes. Linked images available (radiographs, CT). Available supplementary data: Ambulance, 111, 999 data, synthetic data. Non-COPD “controls” Available supplementary support: Analytics, Model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user accs, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.

Webpage:
https://www.healthdatagateway.org/dataset/8fac682b-96be-4e21-a2a9-5fe66c3b35ff

Licence:
Name: HDR UK Innovation Gateway Access
URL: https://www.hdruk.ac.uk/infrastructure/gateway/terms-and-conditions/

Tags:

copd chronic bronchitis emphysema nhs acute exacerbation covid pneumonia pneumonitis news2 deterioration alert sews nebuliser prednisolone steroids corticosteriods oxygen non-invasive ventilation patient acute hospitals inpatient ethnicity multimorbidity blood biomarkers physiology demographics treatments therapies interventions outcomes death longitudinal vital signs

More to explore:

1/20

Previous Next   



Need help integrating and/or managing biomedical data?